No photo of Caroline L Ng

Caroline L Ng, PhD

  • Phone402-552-3035
Calculated based on number of publications stored in Pure and citations from Scopus
20032023

Research activity per year

Network

David A. Fidock

  • Department of Microbiology and Immunology
  • Division of Infectious Diseases
  • Columbia University
  • Department of Microbiology and Immunology
  • Division of Molecular Medicine
  • New York University
  • Department of Medicine

External person

Sergio Wittlin

  • Swiss Tropical Institute
  • University of Basel
  • Swiss Tropical and Public Health Institute
  • University of Basel
  • Department of Medical Parasitology and Infection Biology

External person

Melissa R. Rosenthal

  • University of Nebraska Medical Center
  • University of Nebraska Omaha

External person

Margaret A. Phillips

  • University of Texas Southwestern Medical Center at Dallas
  • Southwestern Medical Center
  • Univ. Texas Southwestern Med. Ctr.
  • University of Texas Southwestern Medical Center
  • Department of Pharmacology
  • Department of Biochemistry
  • Department of Biochemistry
  • University of Texas at Dallas

External person

Elizabeth A. Winzeler

  • University of California at San Diego
  • Department of Pediatrics
  • Department of Pediatrics

External person

Matthew Bogyo

  • Stanford University
  • Department of Microbiology and Immunology
  • Department of Pathology

External person

Michael Delves

  • Imperial College London
  • Department of Life Sciences

External person

Robert Sinden

  • Imperial College London
  • Department of Life Sciences

External person

Andrea Ruecker

  • Imperial College London
  • Department of Life Sciences
  • University of Oxford
  • Mahidol University

External person

Marcus C.S. Lee

  • Malaria Programme
  • Department of Microbiology and Immunology
  • Columbia University
  • Wellcome Trust
  • Wellcome Sanger Institute
  • Malaria Programme
  • Parasites and Microbes Programme
  • Department of Microbiology and Immunology
  • New York University

External person

Jörg J. Möhrle

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture
  • Medicines for Malaria Venture
  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Barbara H. Stokes

  • Department of Microbiology and Immunology
  • Columbia University
  • Department of Microbiology and Immunology

External person

Julie Lotharius

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Koen Dechering

  • TropIQ Health Sciences
  • TropIQ Health Sciences

External person

Arpan Acharya

  • Department of Pharmacology and Experimental Neuroscience
  • University of Nebraska Medical Center

External person

Didier Leroy

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Nathalie Gobeau

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Vicky M. Avery

  • Griffith University Queensland
  • Discovery Biology

External person

Iñigo Angulo-Barturen

  • GlaxoSmithKline
  • Tres Cantos Medicines Development Campus
  • GlaxoSmithKline (GSK)
  • TresCantos Medicines Development Campus
  • Tres Cantos Medicines Development Campus

External person

Maria Lafuente-Monasterio

  • GlaxoSmithKline (GSK)
  • GlaxoSmithKline
  • TresCantos Medicines Development Campus

External person

Martine Clozel

  • Department of Drug Discovery
  • Actelion Pharmaceuticals Ltd.

External person

Kristina Oresic

  • Icahn School of Medicine at Mount Sinai
  • Department of Microbiology
  • One Gustave L. Levy Place

External person

Ralf Brunner

  • Actelion Pharmaceuticals Ltd.
  • University of Basel
  • Swiss Tropical and Public Health Institute
  • Department of Medical Parasitology and Infection Biology

External person

Paula C.A. da Fonseca

  • Medical Research Council
  • MRC Laboratory of Molecular Biology
  • University of Glasgow

External person

Bibia Heidmann

  • Actelion Pharmaceuticals Ltd.
  • Drug Discovery Chemistry and Biology

External person

Christoph Binkert

  • Actelion Pharmaceuticals Ltd.
  • Drug Discovery Chemistry and Biology

External person

T. R.S. Kumar

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University
  • Department of Microbiology and Immunology

External person

James M. Murithi

  • Department of Microbiology and Immunology
  • Columbia University
  • Department of Microbiology and Immunology
  • New York University

External person

Amélie Le Bihan

  • Department of Drug Discovery
  • Actelion Pharmaceuticals Ltd.

External person

Domenico Tortorella

  • Icahn School of Medicine at Mount Sinai
  • Department of Microbiology
  • One Gustave L. Levy Place

External person

Sandra Duffy

  • Griffith University Queensland
  • Discovery Biology

External person

Reto Brun

  • University of Basel
  • Swiss Tropical and Public Health Institute
  • Department of Medical Parasitology and Infection Biology

External person

Laura María Sanz

  • TresCantos Medicines Development Campus
  • GlaxoSmithKline

External person

Xiaoyi Deng

  • University of Texas Southwestern Medical Center
  • Department of Pharmacology
  • Department of Biochemistry
  • Department of Biochemistry

External person

Giulia Siciliano

  • Dipartimento di Malattie Infettive
  • Istituto Superiore di Sanita

External person

Santiago Ferrer

  • GlaxoSmithKline
  • Tres Cantos Medicines Development Campus
  • TresCantos Medicines Development Campus
  • Tres Cantos Medicines Development Campus

External person

María B. Jiménez-Díaz

  • GlaxoSmithKline
  • Tres Cantos Medicines Development Campus
  • GlaxoSmithKline (GSK)
  • TresCantos Medicines Development Campus
  • Tres Cantos Medicines Development Campus

External person

Maria Rosario

  • Takeda Development Center Americas Inc

External person

Farah El Mazouni

  • University of Texas Southwestern Medical Center
  • Department of Pharmacology
  • Department of Biochemistry
  • Department of Biochemistry

External person

Euna Yoo

  • Stanford University

External person

Victoria C. Corey

  • University of California at San Diego
  • Department of Pediatrics

External person

Diana R. Tomchick

  • University of Texas Southwestern Medical Center
  • Department of Biophysics
  • Department of Biophysics
  • University of Texas at Dallas

External person

María S. Martinez

  • GlaxoSmithKline
  • Tres Cantos Medicines Development Campus
  • GlaxoSmithKline (GSK)
  • TresCantos Medicines Development Campus
  • Tres Cantos Medicines Development Campus

External person

Pietro Alano

  • Dipartimento di Malattie Infettive
  • Istituto Superiore di Sanita

External person

Robert W. Sauerwein

  • Radboud University Nijmegen
  • Department of Medical Microbiology
  • TropIQ Health Sciences
  • Department of Medical Microbiology
  • TropIQ Health Sciences

External person

Christoph Boss

  • Actelion Pharmaceuticals Ltd.
  • Drug Discovery Chemistry and Biology

External person

Manu Vanaerschot

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University
  • Department of Microbiology and Immunology

External person

Jade Bath

  • Department of Microbiology and Immunology
  • Columbia University
  • Department of Microbiology and Immunology
  • New York University

External person

Thomas Rückle

  • GeNeuro SA
  • Medicines for Malaria Venture

External person

Pradipsinh K. Rathod

  • University of Washington
  • Department of Chemistry
  • Departments of Chemistry and Global Health

External person

Jeremy N. Burrows

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Nina Lawrence

  • Drug Discovery and Development Centre (H3D)
  • University of Cape Town

External person

Leonardo Lucantoni

  • Discovery Biology
  • Griffith University Queensland

External person

Tessa M. Firestone

  • University of Nebraska Medical Center

External person

Stephen Toovey

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Janet Gahagen

  • SRI International

External person

Amélie Le Bihan

  • Drug Discovery Chemistry and Biology
  • Actelion Pharmaceuticals Ltd.

External person

Ian Bathhurst

  • Medicines for Malaria Venture

External person

Christian Scheurer

  • University of Basel
  • Swiss Tropical Institute
  • University of Basel
  • Swiss Tropical and Public Health Institute

External person

Ingrid B. Müller

  • Bernhard Nocht Institute for Tropical Medicine

External person

Laura Maria Sanz Alonso

  • GlaxoSmithKline (GSK)
  • GlaxoSmithKline

External person

Ioanna Deni

  • Columbia University

External person

Yi Jing Liu

  • Cornell University

External person

Romain Siegrist

  • Drug Discovery Chemistry and Biology
  • Actelion Pharmaceuticals Ltd.

External person

Manuel Llinás

  • Department of Molecular Biology and Lewis
  • Princeton University
  • Department of Biochemistry and Molecular Biology
  • Pennsylvania State University

External person

Josh Sharp

  • Icahn School of Medicine at Mount Sinai
  • Department of Pharmacology and Biological Chemistry

External person

Jenny Legac

  • University of California at San Francisco
  • Department of Medicine

External person

Sarah Schleiferboeck

  • University of Basel
  • Swiss Tropical and Public Health Institute

External person

Paul D. Roepe

  • Department of Chemistry, Biochemistry, and Cellular and Molecular Biology
  • Georgetown University

External person

Philipp P. Henrich

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

Daniel Scanfeld

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

Christoph Fischli

  • University of Basel
  • Swiss Tropical and Public Health Institute

External person

Felix D. Rozenberg

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

Myles H. Akabas

  • Department of Physiology and Biophysics
  • Yeshiva University

External person

Magdia De Jesus

  • Icahn School of Medicine at Mount Sinai
  • Department of Pharmacology and Biological Chemistry

External person

Arnold Garcia

  • University of California at San Diego

External person

Arun Sridhar

  • GlaxoSmithKline

External person

Ruben de Kanter

  • Actelion Pharmaceuticals Ltd.

External person

Joseph L. Derisi

  • University of California at San Francisco
  • Department of Medicine
  • Department of Biochemistry and Biophysics
  • Department of Biochemistry and Biophysics

External person

Karen L. White

  • Monash University
  • Centre for Drug Candidate Optimisation
  • Centre for Drug Candidate Optimisation

External person

Mathew Njoroge

  • Drug Discovery and Development Centre (H3D)
  • University of Cape Town

External person

Susan A. Charman

  • Monash University
  • Monash University (Parkville Campus)
  • Monash Institute of Pharmaceutical Sciences
  • Centre for Drug Candidate Optimisation
  • Centre for Drug Candidate Optimisation
  • Centre for Drug Candidate Optimisation

External person

Yong Kang Zhang

  • Anacor Pharmaceuticals, Inc.
  • Pfizer

External person

Stephan Chalon

  • Medicines for Malaria Venture

External person

M. R.K. Alley

  • Anacor Pharmaceuticals, Inc.
  • Pfizer

External person

Ryan Muir

  • Stanford University

External person

Nicole Andenmatten

  • Medicines for Malaria Venture

External person

Jill M. Combrinck

  • Division of Pharmacology
  • University of Cape Town

External person

John White

  • University of Washington

External person

Terry A. Krulwich

  • Mt. Sinai School of Medicine
  • Mount Sinai School of Medicine
  • Icahn School of Medicine at Mount Sinai
  • Department of Pharmacology and Systems Therapeutics
  • Department of Pharmacology and Biological Chemistry

External person

Paul Jenö

  • Proteomics Core Facility
  • University of Basel

External person

Olivier Lichtarge

  • Computational and Integrative Biomedical Research Center
  • Verna and Marrs McLean Department of Biochemistry
  • Department of Pharmacology
  • Baylor College of Medicine
  • Department of Molecular and Human Genetics

External person

Heekuk Park

  • Columbia University

External person

Nicola Kerr

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Andreas Martin Lisewski

  • Computational and Integrative Biomedical Research Center
  • Baylor College of Medicine
  • Department of Molecular and Human Genetics

External person

Kim Lee Sim

  • Sanaria Inc.
  • Sanaria Inc

External person

Trevor Laird

  • Medicines for Malaria Venture

External person

Jeremiah D. Momper

  • University of California at San Diego

External person

Yvonne R. Freund

  • Anacor Pharmaceuticals, Inc.
  • Pfizer

External person

Sreekanth Kokkonda

  • Departments of Chemistry and Global Health
  • University of Washington

External person

Pedro E. Ferreira

  • University of Minho

External person

Annie N. Cowell

  • University of California at San Diego

External person

Madeline R. Luth

  • University of California at San Diego
  • Department of Pediatrics

External person

Jie Jin

  • Division of Hematology
  • Icahn School of Medicine at Mount Sinai
  • Harvard University
  • Department of Pharmacology and Biological Chemistry
  • Boston Children's Hospital

External person

Kutub Ashraf

  • University of Medicine and Dentistry of New Jersey

External person

William H. Gerwick

  • University of California at San Diego
  • Center for Marine Biotechnology and Biomedicine

External person

Timothy J. Egan

  • University of Cape Town
  • Department of Chemistry

External person

Nina F. Gnädig

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

Suzette Moes

  • Proteomics Core Facility
  • University of Basel

External person

Ric N. Price

  • Global and Tropical Health Division
  • University of Oxford
  • Charles Darwin University

External person

Ebere Sonoiki

  • University of California at Berkeley
  • School of Public Health
  • University of California at San Francisco
  • Department of Medicine

External person

Francisco Javier Gamo Benito

  • GlaxoSmithKline (GSK)
  • GlaxoSmithKline

External person

Aloysus Lawong

  • Department of Biochemistry
  • University of Texas Southwestern Medical Center
  • Department of Biochemistry

External person

Thomas Weller

  • Actelion Pharmaceuticals Ltd.

External person

Raúl Chuquiyauri

  • Asociación Civil Selva Amazónica
  • Universidad Peruana Cayetano Heredia
  • Asociación Civil Selva Amazónica

External person

Sam J. Regenbogen

  • Department of Pharmacology
  • Baylor College of Medicine

External person

Robert H. Arch

  • Takeda Development Center Americas Inc

External person

Kate J. Fairhurst

  • Columbia University

External person

Michelle Paguio

  • Department of Chemistry, Biochemistry, and Cellular and Molecular Biology
  • Georgetown University

External person

Sandra March

  • Institute for Medical Engineering and Science
  • Massachusetts Institute of Technology

External person

Solange Meyer

  • Actelion Pharmaceuticals Ltd.

External person

Opeoluwa O. Oyewole

  • University of Nebraska Medical Center

External person

Purnima Bhanot

  • University of Medicine and Dentistry of New Jersey

External person

Heather Griffith

  • Skirball Inst. of Biomol. Medicine
  • New York University

External person

Xavier Ding

  • Medicines for Malaria Venture

External person

Rintis Noviyanti

  • Eijkman Institute for Molecular Biology

External person

Richard T. Eastman

  • Department of Microbiology and Immunology
  • Columbia University
  • National Institutes of Health
  • Laboratory of Malaria and Vector Research
  • New York University

External person

Ithiel J. Frame

  • Department of Physiology and Biophysics
  • Yeshiva University

External person

Wenhu Zhan

  • Cornell University

External person

M. Isabel Veiga

  • University of Minho

External person

Francisco Javier Gamo

  • GlaxoSmithKline
  • TresCantos Medicines Development Campus

External person

Selina E. Bopp

  • Harvard University
  • Department of Immunology and Infectious Diseases
  • University of California at San Diego
  • Department of Pediatrics

External person

Clemens Kocken

  • Biomedical Primate Research Centre

External person

Renier Van Der Westhuyzen

  • Drug Discovery and Development Centre (H3D)
  • University of Cape Town

External person

Suzanne Elliott

  • Q-Pharm Pty Ltd

External person

Gang Lin

  • Cornell University

External person

Kazutoyo Miura

  • National Institutes of Health
  • Laboratory of Malaria and Vector Research

External person

Laura A. Kirkman

  • Cornell University

External person

Grennady Wirjanata

  • Global and Tropical Health Division
  • Charles Darwin University

External person

Kabita Pandey

  • University of Nebraska Medical Center

External person

Philip J. Rosenthal

  • University of California at San Francisco
  • Department of Medicine
  • Department of Surgery
  • Department of Pediatrics
  • University of Southern California
  • University of Milan
  • University of Nebraska Medical Center
  • Department of Pediatrics
  • Department of Pharmaceutical Chemistry
  • Div. Pediat. Gastroenterol. Nutr.
  • Department of Biomathematics
  • Division of Pediatric Gastroenterology and Nutrition
  • University of California at Los Angeles
  • Rosalind Russell Medical Research Center for Arthritis
  • The EMMES Corporation
  • SPLIT Research Group
  • The EMMES Corporation
  • Div. of Pediat. Gastroenterol./Nutr.

External person

Jehad Almaliti

  • University of California at San Diego
  • University of Jordan

External person

Jutta Marfurt

  • Global and Tropical Health Division
  • Charles Darwin University

External person

Anthony Dayan

  • Medicines for Malaria Venture

External person

Brice Campo

  • Medicines for Malaria Venture

External person

Hamed Aissaoui

  • Drug Discovery Chemistry and Biology
  • Actelion Pharmaceuticals Ltd.

External person

Kurt E. Ward

  • Columbia University

External person

Rachel G. Kasdin

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

Mark Baker

  • GlaxoSmithKline

External person

Christopher Snyder

  • University of Basel
  • Swiss Tropical Institute
  • University of Basel
  • Swiss Tropical and Public Health Institute
  • Actelion Pharmaceuticals Ltd.

External person

Shirin Akbar

  • University of Glasgow

External person

Paul Griffin

  • Q-Pharm Pty Ltd
  • University of Queensland

External person

Lalitha Iyer

  • SRI International

External person

Markus Safferling

  • Skirball Inst. of Biomol. Medicine
  • Bayer CropScience
  • Icahn School of Medicine at Mount Sinai
  • Department of Pharmacology and Biological Chemistry
  • New York University
  • Bayer AG

External person

Corinna Mattheis

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

James S. McCarthy

  • Q-Pharm Pty Ltd
  • Queensland Institute of Medical Research

External person

Mariana J. de Almeida

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

Juan Carlos Hinojosa

  • Asociación Civil Selva Amazónica

External person

Richard W.D. Welford

  • Actelion Pharmaceuticals Ltd.

External person

Kelly Rubiano

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

Chen Dong

  • Anacor Pharmaceuticals, Inc.
  • Pfizer

External person

Ryan D. Imhoff

  • Purdue University

External person

Satish K. Dhingra

  • Department of Microbiology and Immunology
  • Columbia University
  • Department of Microbiology and Immunology

External person

Lidiya Bebrevska

  • Medicines for Malaria Venture

External person

Ori J. Lieberman

  • Columbia University

External person

Thomas Rückle

  • GeNeuro SA
  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Tao Li

  • Sanaria Inc.
  • Sanaria Inc

External person

Pavel Afanasyev

  • Medical Research Council

External person

Roland A. Cooper

  • Department of Natural Sciences and Mathematics
  • Dominican University of California

External person

Lucia Bertuccini

  • Istituto Superiore di Sanita

External person

Anne Catrin Uhlemann

  • Columbia University

External person

Hanna De Jong

  • Stanford University

External person

Gustavo A. Afanador

  • Department of Biochemistry
  • University of Texas Southwestern Medical Center
  • Department of Biochemistry

External person

Lindsey Altenhofen

  • Department of Molecular Biology and Lewis
  • Princeton University
  • Department of Biochemistry and Molecular Biology
  • Pennsylvania State University

External person

Alejandro Llanos-Cuentas

  • Universidad Peruana Cayetano Heredia

External person

Nagireddy Putluri

  • Verna and Marrs McLean Department of Biochemistry
  • Baylor College of Medicine
  • Department of Molecular and Cellular Biology

External person

Noelle S. Williams

  • University of Texas Southwestern Medical Center

External person

Anbu Karani Adikesavan

  • Baylor College of Medicine
  • Department of Molecular and Human Genetics
  • Department of Molecular and Cellular Biology

External person

Sonia Gulati

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

James Louttit

  • GSK
  • GlaxoSmithKline

External person

Vida Ahyong

  • University of California at San Francisco
  • Department of Biochemistry and Biophysics

External person

Daniel P. Flaherty

  • University of Nebraska Medical Center
  • Purdue University
  • Nebraska Medicine

External person

Ed Riccio

  • SRI International

External person

Jiri Gut

  • University of California at San Francisco
  • Rosalind Russell Medical Research Center for Arthritis
  • Department of Medicine

External person

Jacqueline W. Njoroge

  • University of Texas Southwestern Medical Center
  • Department of Pharmacology

External person

Martin Casapia

  • Asociación Civil Selva Amazónica

External person

Stephan Duparc

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Francisco Javier Gamo–Benito

  • TresCantos Medicines Development Campus
  • GlaxoSmithKline

External person

Paul S. Callaghan

  • Department of Chemistry, Biochemistry, and Cellular and Molecular Biology
  • Georgetown University

External person

Stephan Buchmann

  • Actelion Pharmaceuticals Ltd.

External person

Patrick G. Schupp

  • Department of Microbiology and Immunology
  • Columbia University

External person

Yasheen Zhou

  • Anacor Pharmaceuticals, Inc.
  • Pfizer

External person

Mahesh Mohan

  • Tulane University
  • Division of Comparative Pathology
  • Southwest Foundation for Biomedical Research

External person

Daniella S. Bick

  • Columbia University

External person

Omalla A. Olwenyi

  • Department of Pathology and Microbiology
  • University of Nebraska Medical Center
  • Makerere University

External person

Sangeeta N. Bhatia

  • Broad Institute
  • Massachusetts Institute of Technology
  • Harvard University
  • Marble Center for Cancer Nanomedicine
  • Division of Medicine
  • Ludwig Center for Molecular Oncology
  • Department of Electrical Engineering and Computer Science
  • Institute for Medical Engineering and Science

External person

Jacquin C. Niles

  • Massachusetts Institute of Technology
  • Parsons Laboratory

External person

Maëlle Duffey

  • Medicines for Malaria Venture

External person

John N. Haselden

  • GlaxoSmithKline (GSK)
  • GlaxoSmithKline

External person

Charisse Flerida A. Pasaje

  • Massachusetts Institute of Technology
  • Parsons Laboratory

External person

M. John Rogers

  • National Institutes for Allergy and Infectious Diseases

External person

Sonja Ewerling

  • Actelion Pharmaceuticals Ltd.

External person

Nada Araeipour

  • Medicines for Malaria Venture
  • Medicines for Malaria Venture

External person

Judith Straimer

  • Department of Microbiology and Immunology
  • Columbia University
  • New York University

External person

Anthony J. O'Donoghue

  • University of California at San Diego

External person

Kristina S. Wickham

  • SUNY Upstate Medical University

External person

Denghui Guo

  • University of California at San Francisco
  • Department of Medicine

External person

Rosemary Rochford

  • SUNY Upstate Medical University
  • University of Colorado Anschutz Medical Campus

External person

Jon Mirsalis

  • SRI International

External person

Till Voss

  • University of Basel
  • Swiss Tropical and Public Health Institute
  • Department of Medical Parasitology and Infection Biology

External person

Olivier Corminboeuf

  • Drug Discovery Chemistry and Biology
  • Actelion Pharmaceuticals Ltd.

External person

Da Neng Wang

  • Skirball Inst. of Biomol. Medicine
  • New York University

External person

Yi Cui

  • GSK
  • GlaxoSmithKline

External person

Louise Marquart

  • Queensland Institute of Medical Research

External person

Hao Zhang

  • Cornell University

External person

John White

  • Departments of Chemistry and Global Health
  • University of Washington

External person

Anna Marie Zeeman

  • Biomedical Primate Research Centre

External person

Carole Long

  • National Institutes of Health
  • Laboratory of Malaria and Vector Research

External person

Silvana Sekuloski

  • Queensland Institute of Medical Research

External person

Joel P. Quiros

  • Integrative Molecular and Biomedical Sciences Graduate Program
  • Baylor College of Medicine

External person

Rob Hooft Van Huijsduijnen

  • Medicines for Malaria Venture (MMV)
  • Medicines for Malaria Venture

External person

Arun Sreekumar

  • Verna and Marrs McLean Department of Biochemistry
  • Department of Biochemistry and Molecular Biology
  • Baylor College of Medicine
  • Department of Molecular and Cellular Biology

External person

Tomas Yeo

  • Columbia University

External person

Walter Fischli

  • Actelion Pharmaceuticals Ltd.

External person

Stephen L. Hoffman

  • Sanaria Inc.
  • Sanaria Inc

External person

Your message has successfully been sent.
Your message was not sent due to an error.